Free Trial

Nascent Biotech (NBIO) SEC Filings & 10K Form

Nascent Biotech logo
$0.0065 0.00 (0.00%)
As of 04/1/2025

Recent Nascent Biotech SEC Filings

DateFilerForm TypeView
04/01/2025
11:14 AM
Nascent Biotech (Filer)
Form 15-12G
11/15/2024
1:29 PM
Nascent Biotech (Filer)
Form NT 10-Q
07/02/2024
7:50 AM
Carrick Sean (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:51 AM
HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:51 AM
Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:30 PM
Nascent Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2024
12:06 PM
Karas Douglas John (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
12:06 PM
Carrick Sean (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
12:07 PM
HOLDEN LOWELL THOMAS (Reporting)
Nascent Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
11:15 PM
Nascent Biotech (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (OTCMKTS:NBIO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners